Welcome to our dedicated page for Borgwarner SEC filings (Ticker: BWA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BorgWarner Inc. (NYSE: BWA) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detail on trading symbols, dividend declarations, financial results, legal matters, and other material events that affect the company and its securities.
In recent 8-K filings, BorgWarner identifies its common stock, par value $0.01 per share, trading under the symbol BWA on the New York Stock Exchange, and its 1.00% Senior Notes due 2031 trading under the symbol BWA31. The company uses Form 8-K to furnish earnings press releases for its quarterly and year-to-date results, outlining net sales, operating margin, earnings per share, and the impact of non-comparable items. These filings also reference updated guidance ranges for net sales, margins, and cash flow.
Other 8-K items describe Board-approved quarterly cash dividends on BorgWarner’s common stock, specifying per-share amounts, record dates, and payment dates. Filings also address legal and structural matters, such as the settlement with PHINIA Inc. related to value added tax refunds and issues connected to a prior spin-off that created PHINIA as an independent company. In these disclosures, BorgWarner explains how related charges are treated as non-comparable items for earnings presentation.
On Stock Titan, users can review BorgWarner’s SEC filings with AI-powered summaries that help explain the key points of lengthy documents. This includes highlighting the main elements of 10-K annual reports, 10-Q quarterly reports, and 8-K current reports, as well as drawing attention to dividend declarations, guidance updates, and significant legal or transactional disclosures. The filings are updated as they are made available on EDGAR, allowing investors to monitor BorgWarner’s regulatory reporting and capital markets activity in one place.
BorgWarner Inc. (BWA) Form 144 reports a proposed sale of 10,000 common shares through Charles Schwab & Co., Inc. on 09/05/2025 with an aggregate market value of $439,707.00. The filing shows total outstanding shares of 216,392,876. The shares were recently acquired via equity compensation: 4,607 shares from a performance stock lapse on 02/05/2025 and 5,393 shares from a restricted stock lapse on 02/28/2025. No securities of the issuer were reported sold by the reporting person in the past three months. The filing contains standard Rule 144 attestation language but lacks identifying filer CIK and contact details in the provided content.
Insider sale reported: BorgWarner Inc. officer Isabelle McKenzie sold 3,000 shares of Common Stock on 09/04/2025 at $43.45 per share, leaving her with 50,255 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 09/05/2025. The filing identifies McKenzie as a Vice President and a director/officer of the company. No derivative transactions or other changes were reported.
BorgWarner Inc. (BWA) Form 144 shows a proposed sale of 3,000 common shares through Charles Schwab & Co., with an aggregate market value of $130,350 and an approximate sale date of 09/04/2025 on the NYSE. The shares were acquired on 02/05/2025 via a performance stock lapse from BorgWarner Inc. The filing identifies prior disposals by the same person, Isabelle McKenzie, of 10,190 shares during August 2025, generating total gross proceeds of $404,045. Outstanding shares listed are 216,392,876. The filer certifies absence of undisclosed material adverse information and notes compliance with Rule 144 disclosure requirements.
Insider sale by BorgWarner director Alexis P. Michas. The filing reports a sale on 09/02/2025 of 8,772 shares of BorgWarner Inc. (BWA) reported under Form 4. The weighted average price for the sale was $42.3146, with actual prices ranging from $42.2050 to $42.3900. Following the reported transaction, the reporting person beneficially owned 78,903.45 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing does not state proceeds, reasons for the sale, or any additional transactions.
BorgWarner Inc. (BWA) filed a Form 144 notice for a proposed sale of 8,772 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $371,184 and an approximate sale date of 09/02/2025 on the NYSE. The filing lists the acquisition sources and dates for the shares to be sold: restricted stock lapses on 04/24/2024 (3,752 shares) and 04/24/2025 (4,903 shares), and dividend payouts on 04/24/2024 (48 shares) and 04/24/2025 (69 shares); all were received from BorgWarner Inc. and paid as equity compensation. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
Insider sale reported: BorgWarner director and Vice President Isabelle McKenzie disclosed a sale of 2,690 shares of BorgWarner Inc. (BWA) on 08/28/2025 at a reported price of $42.9257 per share, leaving her with 53,255 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/29/2025.
BorgWarner Inc. insider sale notice (Form 144) — This filing reports that an individual received 2,690 shares on 02/05/2025 from a performance stock lapse as equity compensation and intends to sell those 2,690 common shares on 08/28/2025 through Charles Schwab & Co., Inc. at an aggregate market value of $115,470 on the NYSE. The filing also discloses that the same person sold 5,000 shares on 08/04/2025 for $188,550 and 2,500 shares on 08/12/2025 for $100,025. The filer certifies no undisclosed material adverse information.
Isabelle McKenzie, Vice President of BorgWarner Inc. (BWA), reported a sale of common stock on 08/12/2025. She sold 2,500 shares at a weighted average price of approximately $40.0101, with actual prices ranging from $40.0101 to $40.0110. After the sale she beneficially owned 55,945 shares. The Form 4 was signed by Miyuki P. Oshima as attorney-in-fact on 08/14/2025. The filing shows a single, non-derivative disposition and does not include any additional commentary or plans.
Insider sales by BorgWarner director/officer Stefan Demmerle totaling 20,000 shares were reported. The Form 4 shows three separate sell transactions on 08/12/2025 and 08/13/2025: 5,000 shares at a weighted average price of $40.0437 (actual prices ranged $40.04–$40.05), 10,000 shares at $38.95, and 5,000 shares at $40.50. After these transactions the report lists the beneficial ownership balance as 229,039.69 shares (reported following the 08/13/2025 sale). The filing was submitted via attorney-in-fact and includes an explanation that the first sale price is a weighted average and that detailed per-price quantities are available on request.
Harris Associates L.P. and Harris Associates, Inc. report beneficial ownership of 2,772,856 shares of BorgWarner Inc. common stock, representing 1.3% of the class as of the reporting period. The filing states Harris has sole voting power over 2,757,981 shares and sole dispositive power over 2,772,856 shares. The document identifies the issuer's principal office in Auburn Hills, Michigan, and provides Harris’s business address in Chicago. The filing is a Schedule 13G amendment (cover indicates Amendment No. 1) and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The statement is signed by Joseph J. Allessie as General Counsel and Secretary for both reporting entities with signature dates of 08/14/2025.